VEXAS Syndrome: Study Highlights Cutaneous SymptomsJune 20, 2024Rare DiseasesDermatologyRheumatologyMixed Topics
Autoantibodies Nonspecific to Systemic Sclerosis May Play Role in ILD PredictionJune 14, 2024PulmonologyRare DiseasesRheumatology
Upadacitinib Proves Successful in First JAK Inhibitor Trial for Giant Cell ArteritisJune 14, 2024Rare DiseasesRheumatology
FDA Grants New Pediatric Arthritis Indications for UpadacitinibJune 7, 2024Rare DiseasesMusculoskeletal DisordersGastroenterologyDermatologyRheumatology
Inebilizumab ‘MITIGATES’ Flare Risk in IgG4-Related DiseaseJune 7, 2024PulmonologyRare DiseasesNeurologyNephrologyGastroenterology
Don’t Miss the Dx: A 24-Year-Old Man With Sudden-Onset Hematuria, Proteinuria, Edema, and HypertensionMay 22, 2024NephrologyRare Diseases
New British Behçet’s Disease Guidelines Emphasize Multidisciplinary ManagementApril 26, 2024Rare DiseasesRheumatologyGastroenterologyDermatology
Autoimmunity’s Female Bias and the Mysteries of XistApril 2, 2024Rare DiseasesRheumatologyWomen's HealthImmunology
Second FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous FormulationsMarch 8, 2024Rare DiseasesMusculoskeletal DisordersRheumatology
FDA Approves 10th Humira Biosimilar, With InterchangeabilityFebruary 27, 2024GastroenterologyRare DiseasesMusculoskeletal DisordersRheumatologyDermatology
